
Need professional-grade analysis? Visit stockanalysis.com
$143.34B
N/A
N/A
N/A
SanBio Company Limited (4592) trades on Tokyo Stock Exchange in JPY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at JPY2182.00, up 4.35% from the previous close.
Over the past year, 4592 has traded between a low of JPY1525.00 and a high of JPY3850.00. The stock has lost 4.4% over this period. It is currently 43.3% below its 52-week high.
SanBio Company Limited has a market capitalization of $143.34B.
SanBio Company Limited is a healthcare company that focuses on the development, production, and sale of regenerative cell medicines for the central nervous system. The company's lead product candidate, SB623, has completed a phase 2 clinical trial to treat traumatic brain injury in the United States. SanBio operates as a publicly-traded company, with a primary focus on advancing its portfolio of regenerative cell therapies to address unmet medical needs in the field of neurological disorders.
Side-by-side comparison against top Healthcare peers.